Chen’s group found that R-2-hydroxyglutarate (R-2HG), inhibits FTO activity and increases global m6A RNA methylation levels in R-2HG-sensitive AML cells, which reduces the stability of MYC/CEBPA transcripts and related activities of relevant signaling pathways175. The gene discussed is MYC; the disease is acute myeloid leukemia.